SSIs generate costs for society and significant suffering for patients, often involving prolonged periods of hospitalization, which in turn create additional costs. The introduction of stricter hygiene requirements and regulations has made some improvements, but the problem is still a major cause for concern.

A primary cause of SSI is airborne contamination from bacteria-carrying skin particles which can sediment on surfaces sensitive for surgical asepsis. Typically, around 50-200 colony forming units per cubic metre (cfu/m3) of air are found in conventionally ventilated operating rooms. The most common source of bacteria is considered to be the operating theatre personnel working in close proximity to the site of the operation.

Toul Meditech systems are ready for use following delivery and a minimal installation and can be used in different locations within a hospital or shared between hospitals.

• Suitable for ophthalmic surgery
• Minimal training time 
• Fast pre-operative set-up time 
• Safe, hygienic operations with airflow focused on the wound area or the instruments, undisturbed by staff or equipment
• Eliminate risk of contamination of operating tools, implants or prostheses 
• No rebuilding costs required

Altogether the payback time is very short - avoid one infection and the investment has paid for itself.

The installation of Toul Meditech systems is a ‘money-saver" for clinics and for insurance companies - shorter hospital stays, no re-operations, no unnecessary patient suffering caused by infections and no loss of income. The increased number of operations due to a faster flow of patients is also a ‘money earner' for private clinics and insurance companies.

• increased productivity and efficiency 
• reduced cost of patient care 
• faster throughput in operating rooms 
• low running costs 
• ready to use and easy to handle
• no structural alterations needed 
• no air installation needed

Every infection creates unnecessary suffering for the patient and significant cost for the clinic.